Annual EBITDA:
-$151.35M-$123.35M(-440.55%)Summary
- As of today, IMNM annual EBITDA is -$151.35 million, with the most recent change of -$123.35 million (-440.55%) on December 31, 2024.
- During the last 3 years, IMNM annual EBITDA has fallen by -$126.91 million (-519.06%).
- IMNM annual EBITDA is now -2007.11% below its all-time high of -$7.18 million, reached on December 31, 2018.
Performance
IMNM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly EBITDA:
-$59.41M-$13.65M(-29.82%)Summary
- As of today, IMNM quarterly EBITDA is -$59.41 million, with the most recent change of -$13.65 million (-29.82%) on September 30, 2025.
- Over the past year, IMNM quarterly EBITDA has dropped by -$16.16 million (-37.37%).
- IMNM quarterly EBITDA is now -2283.83% below its all-time high of -$2.49 million, reached on March 31, 2020.
Performance
IMNM Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM EBITDA:
-$204.08M-$16.16M(-8.60%)Summary
- As of today, IMNM TTM EBITDA is -$204.08 million, with the most recent change of -$16.16 million (-8.60%) on September 30, 2025.
- Over the past year, IMNM TTM EBITDA has increased by +$104.94 million (+33.96%).
- IMNM TTM EBITDA is now -7853.08% below its all-time high of -$2.57 million, reached on September 30, 2019.
Performance
IMNM TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
IMNM EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1Y1 Year | -440.6% | -37.4% | +34.0% |
| 3Y3 Years | -519.1% | -605.5% | -459.6% |
| 5Y5 Years | -1456.7% | -2149.3% | -2554.1% |
IMNM EBITDA Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
|---|---|---|---|---|---|---|---|
| 3Y | 3-Year | -519.1% | at low | -1274.2% | +55.0% | -830.5% | +34.0% |
| 5Y | 5-Year | -1456.7% | at low | -2149.3% | +55.0% | -2554.1% | +34.0% |
| All-Time | All-Time | -2007.1% | at low | -2283.8% | +55.0% | -7853.1% | +34.0% |
IMNM EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2025 | - | -$59.41M(-29.8%) | -$204.08M(-8.6%) |
| Jun 2025 | - | -$45.76M(-4.2%) | -$187.92M(-3.5%) |
| Mar 2025 | - | -$43.91M(+20.2%) | -$181.49M(+32.7%) |
| Dec 2024 | -$151.35M(-440.6%) | -$55.00M(-27.2%) | -$269.62M(+12.7%) |
| Sep 2024 | - | -$43.24M(-9.9%) | -$309.01M(-14.3%) |
| Jun 2024 | - | -$39.34M(+70.2%) | -$270.24M(-14.3%) |
| Mar 2024 | - | -$132.04M(-39.9%) | -$236.51M(-117.4%) |
| Dec 2023 | -$28.00M(+22.8%) | -$94.40M(-2013.2%) | -$108.80M(-396.1%) |
| Sep 2023 | - | -$4.47M(+20.5%) | -$21.93M(+15.3%) |
| Jun 2023 | - | -$5.62M(-29.9%) | -$25.89M(+11.0%) |
| Mar 2023 | - | -$4.32M(+42.6%) | -$29.07M(+19.8%) |
| Dec 2022 | -$36.27M | -$7.53M(+10.6%) | -$36.27M(+0.5%) |
| Sep 2022 | - | -$8.42M(+4.4%) | -$36.47M(-2.8%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2022 | - | -$8.80M(+23.6%) | -$35.49M(-10.0%) |
| Mar 2022 | - | -$11.52M(-49.1%) | -$32.25M(-31.9%) |
| Dec 2021 | -$24.45M(-43.4%) | -$7.73M(-3.9%) | -$24.45M(-19.0%) |
| Sep 2021 | - | -$7.44M(-33.6%) | -$20.54M(-30.5%) |
| Jun 2021 | - | -$5.57M(-49.6%) | -$15.74M(-23.6%) |
| Mar 2021 | - | -$3.72M(+2.5%) | -$12.73M(-10.7%) |
| Dec 2020 | -$17.04M(-75.3%) | -$3.82M(-44.5%) | -$11.51M(-49.6%) |
| Sep 2020 | - | -$2.64M(-3.3%) | -$7.69M(-1.0%) |
| Jun 2020 | - | -$2.56M(-2.6%) | -$7.61M(-50.5%) |
| Mar 2020 | - | -$2.49M(+2.9%) | -$5.06M(-97.1%) |
| Dec 2019 | -$9.72M(-35.4%) | - | - |
| Sep 2019 | - | -$2.57M | -$2.57M |
| Dec 2018 | -$7.18M | - | - |
FAQ
- What is Immunome, Inc. annual EBITDA?
- What is the all-time high annual EBITDA for Immunome, Inc.?
- What is Immunome, Inc. annual EBITDA year-on-year change?
- What is Immunome, Inc. quarterly EBITDA?
- What is the all-time high quarterly EBITDA for Immunome, Inc.?
- What is Immunome, Inc. quarterly EBITDA year-on-year change?
- What is Immunome, Inc. TTM EBITDA?
- What is the all-time high TTM EBITDA for Immunome, Inc.?
- What is Immunome, Inc. TTM EBITDA year-on-year change?
What is Immunome, Inc. annual EBITDA?
The current annual EBITDA of IMNM is -$151.35M
What is the all-time high annual EBITDA for Immunome, Inc.?
Immunome, Inc. all-time high annual EBITDA is -$7.18M
What is Immunome, Inc. annual EBITDA year-on-year change?
Over the past year, IMNM annual EBITDA has changed by -$123.35M (-440.55%)
What is Immunome, Inc. quarterly EBITDA?
The current quarterly EBITDA of IMNM is -$59.41M
What is the all-time high quarterly EBITDA for Immunome, Inc.?
Immunome, Inc. all-time high quarterly EBITDA is -$2.49M
What is Immunome, Inc. quarterly EBITDA year-on-year change?
Over the past year, IMNM quarterly EBITDA has changed by -$16.16M (-37.37%)
What is Immunome, Inc. TTM EBITDA?
The current TTM EBITDA of IMNM is -$204.08M
What is the all-time high TTM EBITDA for Immunome, Inc.?
Immunome, Inc. all-time high TTM EBITDA is -$2.57M
What is Immunome, Inc. TTM EBITDA year-on-year change?
Over the past year, IMNM TTM EBITDA has changed by +$104.94M (+33.96%)